Verastem cancer drug shows early promise in small study

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 14 Oct, 15:00 UTC

Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and crowded areas of oncology research.

science

Sources

• T2Verastem cancer drug shows early promise in small studyBioPharma Dive / Healthcare Dive / MedTech Dive14 Oct, 15:00